Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
While genetic findings do not predict exact medication response, they may help provide context for why sublingual formulations work well for some patients but not others, supporting a more informed conversation with your provider
If you have diabetic ketoacidosis or a family history of a certain type of thyroid cancer, you may not be a good candidate for the injection
Login/Sign Up Login/Sign Up 1040 with coupons & bank offers*
Optimal dietary patterns for prevention of chronic disease [published correction appears in Nat Med
Key Takeaways Retatrutide is a once-weekly injectable triple agonist targeting GLP-1, GIP, and glucagon receptors Starting dose is typically 1 mg weekly, titrating up gradually to minimize side effects Maintenance doses range from 8 mg to 12 mg weekly based on individual response Titration is critical for balancing weight loss efficacy with tolerability Clinical trials show significant weight reduction compared to placebo Always work with a healthcare provider to determine your optimal dosing schedule Overview of Retatrutide What is Retatrutide
US$ 21.05
US$ 20.46
US$ 25.23
US$ 25.29
:max_bytes(150000):strip_icc()/Health-GettyImages-1675158771-70640c9fdf1b41078975cfc3fd538a6b.jpg)
US$ 27.93
